Publication | Closed Access

3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions

Percutaneous Coronary InterventionCardiovascular DiseaseCoronary Unit3-Year Clinical Follow-upCardiologyMedicineAtherosclerosisCoronary Artery Disease